Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Reset all filters
01 4SANOFI VACCINES CANADA LTD.
02 3GLAXOSMITHKLINE INC
03 2PFIZER CANADA ULC
Reset all filters
01 1MENINGOCOCCAL GROUP A OLIGOSACCHARIDE
02 1MENINGOCOCCAL GROUP A POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
03 2MENINGOCOCCAL GROUP C OLIGOSACCHARIDE
04 1MENINGOCOCCAL GROUP C POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
05 1MENINGOCOCCAL GROUP W POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
06 1MENINGOCOCCAL GROUP Y POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
07 1MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C
08 1MENINGOCOCCAL POLYSACCHARIDE VACCINE GRP C
Reset all filters
01 1POWDER FOR SOLUTION
02 6SOLUTION
03 2SUSPENSION
Reset all filters
01 1MENJUGATE LIQUID
02 4MENQUADFI
03 2MENVEO
04 1NEISVAC-C
05 1NIMENRIX
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL GROUP Y POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
Brand Name : MENQUADFI
Dosage Form : SOLUTION
Dosage Strength : 10MCG/0.5ML
Packaging :
Approval Date :
Application Number : 2507161
Regulatory Info : SCHEDULE D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL GROUP A POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
Brand Name : MENQUADFI
Dosage Form : SOLUTION
Dosage Strength : 10MCG/0.5ML
Packaging :
Approval Date :
Application Number : 2507161
Regulatory Info : SCHEDULE D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL GROUP W POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
Brand Name : MENQUADFI
Dosage Form : SOLUTION
Dosage Strength : 10MCG/0.5ML
Packaging :
Approval Date :
Application Number : 2507161
Regulatory Info : SCHEDULE D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL GROUP C POLYSACCHARIDE-TETANUS TOXOID CONJUGATE
Brand Name : MENQUADFI
Dosage Form : SOLUTION
Dosage Strength : 10MCG/0.5ML
Packaging :
Approval Date :
Application Number : 2507161
Regulatory Info : SCHEDULE D
Registration Country : Canada
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL GROUP A OLIGOSACCHARIDE
Brand Name : MENVEO
Dosage Form : SOLUTION
Dosage Strength : 10MCG/0.5ML
Packaging : 0.5ML
Approval Date :
Application Number : 2347393
Regulatory Info : SCHEDULE D
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL GROUP C OLIGOSACCHARIDE
Brand Name : MENVEO
Dosage Form : SOLUTION
Dosage Strength : 5MCG/0.5ML
Packaging : 0.5ML
Approval Date :
Application Number : 2347393
Regulatory Info : SCHEDULE D
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL GROUP C OLIGOSACCHARIDE
Brand Name : MENJUGATE LIQUID
Dosage Form : SUSPENSION
Dosage Strength : 10MCG/0.5ML
Packaging : 0.5ML
Approval Date :
Application Number : 2440709
Regulatory Info : SCHEDULE D
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL POLYSACCHARIDE VACCINE GRP C
Brand Name : NEISVAC-C
Dosage Form : SUSPENSION
Dosage Strength : 10MCG/0.5ML
Packaging : 0.5ML/10X0.5ML/20X0.5ML
Approval Date :
Application Number : 2245057
Regulatory Info : SCHEDULE D
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : SCHEDULE D
Registration Country : Canada
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C
Brand Name : NIMENRIX
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 5MCG/0.5ML
Packaging : 0.5ML/10X0.5ML
Approval Date :
Application Number : 2402904
Regulatory Info : SCHEDULE D
Registration Country : Canada
